Ignite Creation Date:
2024-10-26 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 3:37 PM
Study NCT ID:
NCT06554301
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-08-12
Brief Title:
A Study on the Efficacy and Safety of Empagliflozin in the Treatment of Pulmonary Arterial Hypertension
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Study on the Efficacy and Safety of Empagliflozin in the Treatment of Pulmonary Arterial Hypertension
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this clinical trial is to learn if empagliflozin works to treat patients with pulmonary arterial hypertension It will also learn about the safety of empagliflozin The main questions it aims to answer are
Based on standard treatment does empagliflozin reduce pulmonary artery pressure and improve cardiac function in patients with pulmonary arterial hypertension What medical problems do participants have when taking empagliflozin Researchers will compare empagliflozin to a placebo a look-alike substance that contains no drug to see if empagliflozin works to treat patients with pulmonary arterial hypertension
Participants will
Take empagliflozin or a placebo every day for 12 weeks Visit the clinic once every 4 weeks for checkups and tests Keep a diary of their symptoms and the drug taking situation
Based on standard treatment does empagliflozin reduce pulmonary artery pressure and improve cardiac function in patients with pulmonary arterial hypertension What medical problems do participants have when taking empagliflozin Researchers will compare empagliflozin to a placebo a look-alike substance that contains no drug to see if empagliflozin works to treat patients with pulmonary arterial hypertension
Participants will
Take empagliflozin or a placebo every day for 12 weeks Visit the clinic once every 4 weeks for checkups and tests Keep a diary of their symptoms and the drug taking situation
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None